Phase 2 Study of Tucatinib vs Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer; HER2CLIMB

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitlePhase 2 Study of Tucatinib vs Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer; HER2CLIMB
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsAndrew Brenner